Organization: Health Canada
Year: 2023
Month: June
Request Number: A-2022-001254
Request Summary: Adverse Drug Reactions (ADRs) for ADDERALL XR. Report numbers: 001014527, 001014585. ADRs for MESALAZINE. Report numbers: E2B_05856871, E2B_05825841, 001021058, 001021238, 001017639, 001021244, 001016207, 001016211.
Disposition: Disclosed in part
Number of pages: 33